Circadian activity of the hypothalamicpituitaryadrenal axis is differentially affected in the rat chronic mild stress model of depression

Stress

Volumn 15, Issue 6, 2012, Pages 647-657

  Christiansen, S ^a   Bouzinova, E V ^a   Palme, R ^b   Wiborg, O ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Chronic mild stress; Corticosterone; Depression; Dexamethasone; Hypothalamicpituitaryadrenal axis; Stress resilience

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; SUCROSE; CORTICOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC MILD STRESS; CIRCADIAN RHYTHM; DEPRESSION; ENZYME IMMUNOASSAY; FECES ANALYSIS; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; ANIMAL; CHEMISTRY; FECES; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CIRCADIAN RHYTHM; CORTICOSTERONE; DEPRESSION; DEXAMETHASONE; FECES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS;

EID: 84859733051     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2011.654370     Document Type: Article

References (42)

1. Antonijevic I. 2008. HPA axis and sleep: Identifying subtypes of majordepression. Stress 11:15-27.
2. Antonijevic IA, Murck H, Frieboes RM, Steiger A. 2000. Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls\-part II: Hormone secretion. Sleep Res Online. 3:15-21.
3. Banki CM, Arato M, Papp Z, Rihmer Z, Kovacs Z. 1986. Associations among dexamethasone non-suppression and TRH- induced hormonal responses: Increased specificity for melanch- olia? Psychoneuroendocrinology 11:205-211. (Pubitemid 16099994)
4. Barone FC, Deegan JF, Price WJ, Fowler PJ, Fondacaro JD, Ormsbee HS, III. 1990. Cold-restraint stress increases rat fecal pellet output and colonic transit. Am J Physiol 258: G329-G337. (Pubitemid 20116440)
5. Barrett EJ. 2009. Organization ofendocrine control. In: Boron WF, Boulpaep EL, editors. Medical physiology. Philadelphia, PA: Saunders/Elsevier. p 1003-1017.
6. Calfa G, Kademian S, Ceschin D, Vega G, Rabinovich GA, Volosin M. 2003. Characterization and functional significance of glucocorticoid receptors in patients with major depression: Modulation by antidepressant treatment. Psychoneuroendocri- nology 28:687-701. (Pubitemid 36522729)
7. Caroff S, Winokur A, Rieger W, Schweizer E, Amsterdam J. 1983. Response to dexamethasone in psychotic depression. Psychiatry Res. 8:59-64. (Pubitemid 13223824)
8. Carroll BJ. 1982. Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychia- tria. 15:19-25.
9. Checkley S. 1996. The neuroendocrinology of depression and chronic stress. Br Med Bull 52:597-617. (Pubitemid 26329157)
10. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301. (Pubitemid 29117816)
11. Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I. 1997. Diurnal activity and pulsatility of the hypothalamus-pituitary- adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234-238. (Pubitemid 27021303)
12. Dinan TG. 1994. Glucocorticoids and the genesis of depressive illness. Apsychobiological model. Br JPsychiatry 164:365-371. (Pubitemid 24095296)
13. Gold PW, Licinio J, Wong ML, Chrousos GP. 1995. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NYAcad Sci 771:716-729. (Pubitemid 26077448)
14. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. 2005. Neuroendocrine and cytokine profile of chronic mild stress- induced anhedonia. Physiol Behav 84:697-706. (Pubitemid 40693431)
15. Gronli J, Murison R, Bjorvatn B, Sorensen E, Portas CM, Ursin R. 2004. Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Res 150:139-147. (Pubitemid 38368965)
16. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, Wiborg O. 2009. Cognitive deficits in the rat chronic mild stress model for depression: Relation to anhedonic- like responses. Behav Brain Res 198:136-141.
17. Jarque CM, Bera AK. 1980. Efficient tests for normality, homoscedasticity and serial independence of regression residuals. Econ Lett 6:255-259.
18. Jayatissa MN, Bisgaard C, Tingstrom A, Papp M, Wiborg O. 2006. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 31:2395-2404. (Pubitemid 44607057)
19. Kathol RG, Jaeckle RS, Lopez JF, Meller WH. 1989. Pathophysiol- ogy of HPA axis abnormalities in patients with major depression: An update. Am J Psychiatry 146:311-317. (Pubitemid 19078191)
20. Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. 2004. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolac- tin in depression. J Psychiatr Res 38:503-511. (Pubitemid 39221758)
21. Lepschy M, Touma C, Palme R. 2010. Faecal glucocorticoid metabolites: How to express yourself\-comparison of absolute amounts versus concentrations in samples from a study in laboratory rats. Lab Anim 44:192-198.
22. Lepschy M, Touma C, Hruby R, Palme R. 2007. Non-invasive measurement of adrenocortical activity in male and female rats. Lab Anim 41:372-387. (Pubitemid 47195609)
23. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Golstein J, Brasseur M, Copinschi G, Van CE. 1987. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment. J Clin Endocrinol Metab 65:141-152. (Pubitemid 17092102)
24. Maes M. 1999. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25-46.
25. Nemenyi PB. 1963. Distribution-free multiple comparisons. Doctoral thesis. Princeton University
26. Nemeroff CB, Vale WW. 2005. The neurobiology of depression: Inroads to treatment and new drug discovery. J Clin Psychiatry 66:5-13. (Pubitemid 41345489)
27. Palacios R, Campo A, Henningsen K, Verhoye M, Poot D, Dijkstra J, Van AJ, Benveniste H, Sijbers J, Wiborg O, Van der LA. 2011. Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biol Psychiatry 70:449-457.
28. Pariante CM. 2006. The glucocorticoid receptor: Part of the solution or part of the problem? J Psychopharmacol 20:79-84. (Pubitemid 44576663)
29. Pariante CM, Miller AH. 2001. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404. (Pubitemid 32234301)
30. Pittenger C, Duman RS. 2008. Stress, depression, and neuro- plasticity: A convergence of mechanisms. Neuropsychopharma- cology. 33:88-109.
31. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL. 1987. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 44:328-336. (Pubitemid 17051320)
32. Shapiro SS, Wilk MB. 1965. An analysis of variance test for normality (complete samples). Biometrika 52:591-611.
33. Stetler C, Miller GE. 2011. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades ofresearch. Psychosom Med 73:114-126.
34. Streeten DH, Anderson GH, Jr., Dalakos TG, Seeley D, Mallov JS, Eusebio R, Sunderlin FS, Badawy SZ, King RB. 1984. Normal and abnormal function of the hypothalamic-pituitary-adreno-cortical system in man. Endocr Rev 5:371-394.
35. Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C, Palme R, Griebel G, Ibarguen-Vargas Y, Hen R, Belzung C. 2011. Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry 16:1177-1188.
36. Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstatter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R. 2008. Mice selected for high versus low stress reactivity: A new animal model for affective disorders. Psychoneuroendocri-nology 33:839-862.
37. Touma C, Fenzl T, Ruschel J, Palme R, Holsboer F, Kimura M, Landgraf R. 2009. Rhythmicity in mice selected for extremes in stress reactivity: Behavioural, endocrine and sleep changes resembling endophenotypes of major depression. PLo S. One. 4: e4325.
38. Touma C, Palme R, Sachser N. 2004. Analyzing corticosterone metabolites in fecal samples ofmice: A noninvasive technique to monitor stress hormones. Horm Behav 45:10-22. (Pubitemid 38083330)
39. Touma C, Sachser N, Mostl E, Palme R. 2003. Effects ofsex and time of day on metabolism and excretion of corticosterone in urine and feces ofmice. Gen Comp Endocrinol 130:267-278. (Pubitemid 36207609)
40. Willner P. 1997. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl) 134:319-329. (Pubitemid 28023396)
41. Willner P. 2005. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 52:90-110. (Pubitemid 41160326)
42. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, Mc Cutcheon IE, Geracioti TD, Jr., De Bellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, Mc Cann SM, Gold PW. 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortiso-lism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97:325-330. (Pubitemid 30055830)